{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:57:11Z","timestamp":1776873431733,"version":"3.51.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-traumatic splenic rupture (NSR) is a rare manifestation of systemic amyloid light-chain amyloidosis (AL amyloidosis), a plasma cell dyscrasia best known for its cardiorenal involvement. This case is unique because the diagnostic clue from NSR was initially overlooked until the underlying disease unfolded into a multisystem disorder. The diagnostic clues were further obscured by the presence of chronic hepatitis B (HBV) and primary biliary cholangitis (PBC). The pitfalls and challenges, as well as the pathogenic link between AL amyloidosis and coexisting conditions, i.e., chronic HBV infection and PBC, are discussed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 46-year-old woman presented initially with non-specific upper gastrointestinal symptoms. Initial workup established the diagnosis of chronic HBV infection and PBC, but the disease progressed despite etiological therapy. NSR occurred 4\u202fmonths later, and splenectomy pathology was inconclusive. The disease progressed, manifesting as cardiac dysfunction, acute kidney injury, subnephrotic-range proteinuria, and hepatomegaly. Serum and urinary-free light-chain levels and ratios were abnormal. Cardiac MRI suggested myocardial hypertrophy. Biopsy of the liver, bone marrow, and re-examination of the splenic specimen showed extensive amyloid deposition. She was diagnosed with multisystem AL amyloidosis (Mayo 2012 Stage III) and started on daratumumab, leading to significant clinical improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the risk of \u201cpremature\u201d attribution of manifestations of rare diseases to common comorbidities. While NSR should always be considered a sentinel event for systemic amyloidosis, the diagnostic clues can be easily overlooked in complex patients with overlapping diagnoses. A high index of suspicion and targeted histological evaluation of splenic tissue are imperative to avoid diagnostic delay and enable earlier treatment initiation for this serious disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1807002","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:08:37Z","timestamp":1776870517000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Systemic amyloidosis unmasked by progressive hepatomegaly after splenectomy for non-traumatic spleen rupture in a patient with chronic liver disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Li-Ping","family":"Sheng","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Center for Liver Diseases, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Yun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Zhi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Fang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Center for Liver Diseases, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Na","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Center for Liver Diseases, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beijing Youan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Qin","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Center for Liver Diseases, Peking University International Hospital","place":["Beijing, China"]},{"name":"Department of Infectious Diseases, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Center for Liver Diseases, Peking University International Hospital","place":["Beijing, China"]},{"name":"Department of Infectious Diseases, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000506696","article-title":"The pathology of amyloidosis in classification: a review","volume":"143","author":"Picken","year":"2020","journal-title":"Acta Haematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1182\/blood-2025-4564","article-title":"Shifting symptom profiles and accelerated diagnosis in AL amyloidosis: findings from ARC community surveys 2022\u20132024","volume":"146","author":"Rebello","year":"2025","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41408-024-01040-8","article-title":"Timing and co-occurrence of symptoms prior to a diagnosis of light chain (AL) amyloidosis","author":"D\u2019Souza","year":"2024","journal-title":"Blood Cancer J"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1200\/JCO.2013.50.0892","article-title":"Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis","volume":"32","author":"Weiss","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nrneph.2013.171","article-title":"Pathophysiology and treatment of systemic amyloidosis","volume":"9","author":"Gillmore","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gut.42.5.727.","article-title":"The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients","volume":"42","author":"Lovat","year":"1998","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"6676407","DOI":"10.1155\/2021\/6676407.","article-title":"Spontaneous splenic artery rupture as the first symptom of systemic amyloidosis","volume":"2021","author":"Bruserud","year":"2021","journal-title":"Case Rep Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/hematolrep15020038","article-title":"Splenic rupture secondary to amyloidosis: a case report and review of the literature","volume":"15","author":"Bahmad","year":"2023","journal-title":"Hematol Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/BF01691260","article-title":"Spontaneous rupture of the spleen complicating portal hypertension","volume":"9","author":"Thijs","year":"1983","journal-title":"Intensive Care Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1527701","DOI":"10.3389\/fmed.2025.1527701","article-title":"Spontaneous splenic rupture associated with Q fever and portal hypertension: a case report","volume":"12","author":"Mustafiz","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1182\/blood-2019-124250","article-title":"Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis: data from 1,313 US commercially insured patients between 2006\u20132018","volume":"134","author":"Hester","year":"2019","journal-title":"Blood"},{"key":"ref13","first-page":"78","article-title":"Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995. 1913 to 1962: 2,056 patients","volume":"169","author":"O\u2019Reilly","year":"1998","journal-title":"West J Med"},{"key":"ref14","first-page":"88","article-title":"Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995. 1963 to 1995: 449 patients","volume":"169","author":"O\u2019Reilly","year":"1998","journal-title":"West J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1186\/s12885-025-14420-5","article-title":"Hepatitis B and C virus infection and risk of multiple myeloma: a systematic review and meta-analysis","volume":"25","author":"Zamani","year":"2025","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.4103\/ijmr.IJMR_2170_19","article-title":"Hepatitis B virus associated localized laryngeal amyloidosis","volume":"152","author":"Sakthivel","year":"2020","journal-title":"Indian J Med Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1007\/s11096-023-01608-7","article-title":"Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis","volume":"45","author":"Moore","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.gastro.2024.11.008","article-title":"AGA clinical practice guideline on the prevention and treatment of hepatitis B virus reactivation in at-risk individuals","volume":"168","author":"Ali","year":"2025","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/hep.510260506","article-title":"Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis","volume":"26","author":"Z\u00fcchner","year":"1997","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1515\/cclm-2025-0357","article-title":"Clinical significance of anti-mitochondrial antibodies and PBC-specific anti-nuclear antibodies in evaluating atypical primary biliary cholangitis with normal alkaline phosphatase levels","volume":"63","author":"Li","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/cld.1158","article-title":"Diagnosis and treatment of primary biliary cholangitis: a patient-friendly summary of the 2018 AASLD practice guidance","volume":"18","author":"Horwich","year":"2021","journal-title":"Clin Liver Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.14309\/ajg.0000000000000338","article-title":"Long-standing unresolved primary biliary cholangitis leading to systemic amyloid a amyloidosis with predominant liver involvement: a death case","volume":"114","author":"Zhang","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1023\/b:ddas.0000037812.86212.99","article-title":"Primary biliary cirrhosis and systemic amyloidosis, a new association","volume":"49","author":"Rodriguez-Luna","year":"2004","journal-title":"Dig Dis Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e70373","DOI":"10.1111\/liv.70373","article-title":"The depletion of plasma cells but not CD20+B cells alleviates primary biliary cholangitis","volume":"45","author":"Zhang","year":"2025","journal-title":"Liver Int"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1081098","DOI":"10.3389\/fcvm.2022.1081098","article-title":"Amyloidosis: what does pathology offer? The evolving field of tissue biopsy","volume":"9","author":"Riefolo","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1002\/cld.148","article-title":"Role of special stains in diagnostic liver pathology","volume":"2","author":"Krishna","year":"2013","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref29","first-page":"648","volume-title":"Macsween\u2019s Pathology of the Liver","author":"Bedossa","year":"2017"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5858\/arpa.2025-0275-CP","article-title":"Laboratory workup of amyloidosis","volume":"150","author":"Miller","year":"2025","journal-title":"Arch Pathol Lab Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3350\/cmh.2024.0609","article-title":"Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis","volume":"31","author":"Wang","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"C130","DOI":"10.1093\/eurheartjsupp\/suad015","article-title":"Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies","volume":"25","author":"Aquaro","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.1182\/blood-2022-162694","article-title":"Evaluation of the path to diagnosis and time to treatment in patients with light-chain amyloidosis using the komodo claims database","volume":"140","author":"Catini","year":"2022","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"944503","DOI":"10.3389\/fonc.2022.944503","article-title":"Real world data on light chain cardiac amyloidosis: still a delayed diagnosis","volume":"12","author":"Chatzileontiadou","year":"2022","journal-title":"Front Oncol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajh.10389","article-title":"Spontaneous rupture of the spleen in AL amyloidosis","volume":"74","author":"Oran","year":"2003","journal-title":"Am J Hematol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1177\/0300060518814337","article-title":"Multiorgan involvement by amyloid light chain amyloidosis","volume":"47","author":"Li","year":"2019","journal-title":"J Int Med Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1807002\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:08:40Z","timestamp":1776870520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1807002\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":38,"alternative-id":["10.3389\/fmed.2026.1807002"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1807002","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1807002"}}